ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Implementation of digital pathology in the workflow for an integrated health system

9th World Digital Pathology & Pathologists Congress

Douglas J Hartman

University of Pittsburgh Medical Center, USA

Posters & Accepted Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681.C1.029

Abstract
The University of Pittsburgh Medical Center (UPMC) has been at the forefront of implementing and adopting digital pathology. UPMC is an integrated health delivery system, operating more than 20 academic, community and specialty hospitals, more than 500 doctors� offices and outpatient sites, employs nearly 3,600 physicians and offers an array of rehabilitation, retirement and long-term care facilities. Digital pathology has included telepathology as well as primary signout. I will discuss the lessons learned from early adoption and recommendations for the optimal utilization of digital pathology will be discussed. We have begun integrating digital pathology in a prospective, in-line fashion within the workflow of our laboratory and this process will be discussed. Some of these lessons include the workflow within the histology/gross laboratory (pre-Imaging variables) as well for the pathologist sign-out work. Additionally, our telepathology efforts will be discussed. We have developed relationships with other sites in the United States as well as several international sites. We have also begun the process of integrating image analysis into the routine workflow for diagnostic pathology. Future areas for development in the field of digital pathology will also be discussed.
Biography

Email: hartmandj@upmc.edu

Top